Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 79 for “"Proteolysis Targeting Chimeras"”.
-
Novel glycomimetic inhibitors and proteolysis-targeting chimeras for human galectins
… we designed and synthesized two proteolysis-targeting chimeras (PROTACs) for human galectins to investigate whether galectins are amenable to targeted protein degradation. Although both compounds displayed nanomolar affinities for galectin-3, they failed to induce galectin-3 …
-
Development of Proteolysis Targeting Chimeras Prodrugs Targeting Cancer and Senescence
Proteolysis targeting chimeras (PROTACs) is an emerging therapeutic modality that recruits the cell’s ubiquitin-proteasome system to degrade the target protein by bringing the protein and an E3 ligase together. The technology has been demonstrated in the treatment of various disorders, including …
-
Induced Degradation of G-Protein-Coupled Receptors Through Proteolysis Targeting Chimeras
… roles in cancer progression. TPD methods include proteolysis targeting chimeras (PROTACs), which are heterobifunctional molecules where one end has a ligand for the protein-of-interest (POI), and the other end has an E3 ligase recruiting ligand. PROTACs take advantage of the ubiquitin-proteasome …
-
Exploring CBL as an E3 ubiquitin ligase in proteolysis-targeting chimeras (PROTACs)
Abstract not currently available.
-
Investigations of the synthesis and properties of romodomain and extra-terminal domain proteolysis targeting chimeras
Hijacking a cell’s ubiquitin proteasome system using PROTAC technology has the potential to be a powerful new therapeutic strategy. Some of the main advantages of this technology include the potential for PROTACs to be catalytic in activity and elicit long-lasting therapeutic effects, offering the …
-
Advanced Mesoporous Particles for Colon-targeted Delivery: Insights into Enhanced Delivery of Proteolysis-targeting Chimeras
Proteolysis-targeting Chimeras (PROTACs) are revolutionary molecules that induce target protein degradation and, therefore, are suited for intractable drug targets. However, they challenge traditional delivery methods for small molecules via the oral route due to their complex physiochemical …
-
Proteolysis Targeting Chimeras (PROTACs) for the Degradation of the Epigenetic Regulators CBP/EP300 and BAZ2A/BAZ2B
Proteolysis Targeting Chimeras (PROTACs) are a novel class of bifunctional small molecules that trigger protein degradation by hijacking the cellular proteolysis machinery, i.e., the ubiquitin-proteasome System (UPS). These bifunctional probes typically consist of a ligand for the protein of …
-
Proteolysis Targeting Chimeras: proteasomal degradation of platelet BTK and TEC as a novel approach in thrombosis prevention
… recently developed small molecule degraders (PROteolysis TArgeting Chimeras, PROTACs) that utilise the proteasomal system to degrade BTK. Human platelet rich plasma (PRP) was treated with various concentrations of PROTACs and were subjected to immunoblotting and assessed for integrin αIIbβ₃ …
-
Design and Synthesis of Bimetallic Catalyst and Multifunctional Peptide Catalysis for Organic Synthesis and Synthesis of Proteolysis Targeting Chimeras (PROTACs) for Sphk1 and Sphk2
… 7, we described our efforts to develop Protease Targeting Chimeras (PROTACs) for selective protein degradation of Sphk1 and Sphk2 in pancreatic cancer cell lines. We synthesized a library of different PROTACs with different linkers with different lengths that include the aliphatic carbon chains, …
-
Development of Hoveyda-Grubbs-Type Precatalysts and Isocyanide-Based Metal Scavengers and Their Applications in the Synthesis of Pharmacologically-Relevant Molecules
… study, olefin metathesis was used to prepared proteolysis-targeting chimeras. Two different E3 ubiquitin ligases were targeted for the degradation of HER-2 tyrosine kinase. The synthesis of alkene-containing protein ligands, subsequent olefin cross-metathesis, and alkene reduction afforded a …
-
Machine Learning for PROTAC Decomposition and Enhanced Degradation Prediction
PROTACs (Proteolysis Targeting Chimeras) are bifunctional molecules composed of three components that mediate the degradation of target proteins, and are widely used in drug discovery. This project explores the application of machine learning in two key aspects: splitting PROTAC molecules into …
-
Targeted protein degradation of the Y220C-p53 mutant as a potential anti-cancer strategy
Targeted protein degradation and Proteolysis Targeting Chimeras (PROTACs) in particular, have become an exciting new field in the drug discovery world, with the potential to target previously seen as ‘undruggable’ proteins. With many PROTACs now reaching the clinic, it is clear that these new …
-
Modulation of Receptor Tyrosine Kinases Using Ubiquitin Variant Induced Proximity
… and protein research. Degradation occurs through proteolysis targeting chimeras, which recruit ubiquitin ligase proteins (E3 ligase) to a target protein to facilitate ubiquitination. By contrast, stabilization occurs through deubiquitinase targeting chimeras, which remove ubiquitin moieties. These …
-
Σχεδιασμός και σύνθεση αναστολέων των κινασών MARK
… indolocarbazoles, b) acridone derivatives and c) proteolysis targeting chimeras bearing acridone. In the first part of the present thesis, bisindole pyrroles and indolocarbazoles were designed as potential MARK4 inhibitors. Both structures and the designed synthetic route were inspired by the …
-
PROTACs – A Novel and Rapidly Developing Field of Targeted Protein Degradation
… the realm of targeted protein degradation called Proteolysis-Targeting Chimeras (PROTACs). This technology specifically targets and degrades disease-causing proteins via the ubiquitin-proteasome system, and has seen an explosion of research and intrigue in both academia and industry over the past …
-
Discovery of DYR684, a First-in-Class DYRK1A/B PROTAC
… Here we report the development of DYRK1 proteolysis targeting chimeras (PROTACs) that combine a new ATP-competitive DYRK1 inhibitor with ligands for the E3 ubiquitin ligase component Cereblon (CRBN) to induce ubiquitination and subsequent proteasomal degradation of DYRK1A and DYRK1B. The …
-
Σχεδιασμός και Ανάπτυξη νέων PROTACs έναντι της P38α κινάσης
… στην πρωτεΐνη P38α. Η τεχνολογία των PROTACs (PROteolysis TArgeting Chimeras) προσφέρει μια καινοτόμο στρατηγική φαρμακευτικής παρέμβασης, επιτρέποντας την επιλεκτική αποδόμηση πρωτεϊνών μέσω της χρήσης του συστήματος ουβικιτίνης-πρωτεασώματος. Είναι σύνθετα μόρια που αποτελούνται από τρία …
-
Branched peptide-based targeted protein degraders for the modulation of ternary complex geometry
Proteolysis Targeting Chimeras (PROTACs) are heterobifunctional targeted protein degraders that selectively degrade a protein of interest (POI) by recruiting innate protein degradation machinery. The current PROTAC design landscape is limited by the use of small molecules as ligands which are …
-
Exploring linker fluorination to optimise PROTAC potency, selectivity, and physical properties
PROteolysis TArgeting Chimeras (PROTACs) have emerged as an exciting new modality in drug discovery for catalytically inducing targeted protein degradation. They consist of protein binding ligands for an E3 ubiquitin ligase and the protein to be degraded joined together by a linker, the length and …
Page 1 of 4